Wutah dodolan YoY sajrone 12 wulan kepungkur: nephros.com (NEPH)

The 12-month YoY sales growth chart confirms the expansion of Nephros, Inc. (NEPH) into the commercial sector and the demand for medical filters. The 20.20 level reflects the current magnitude of this trend. Diversified assembly of purification systems and high margins ensure stability. Success is based on the retention of rare development engineers, which prevents the loss of key competencies in the narrow ultrafiltration segment.
Ringkesan rincian data analitis Nephros, Inc. (NEPH)

This indicator measures revenue dynamics over the last twelve months, determining the pace of business expansion relative to the previous year. A stable trend confirms the company's fundamental resilience to market volatility. By analyzing the year-over-year sales growth percentage for the TTM, an investor can assess the effectiveness of the scaling strategy and the cost of defending the position. For Nephros, Inc. (NEPH), this chart reflects management's success in maintaining a monopoly niche in filtration. Strict adherence to FDA standards converts directly into growth in operating income.